TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    Healthy Dialogue

    Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world’s leading experts to explore the most pressing issues in health and health care.

    Advertise

    Copyright: © American Medical Association, 2020

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Concerning Mortality Rate Trends in the US Aug 29, 2024
    Show notes

    The abating COVID-19 pandemic brings attention to rising mortality rates from non-COVID causes in the US, a trend that predates the COVID-19 pandemic. Viewpoint author Steven H. Woolf, MD, MPH, discusses this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content:

    • Increasing Mortality Rates in the US, but Not From COVID-19

    Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant Aug 22, 2024
    Show notes

    Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:

    • Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
    • A New Era in Menopause Management?

    Long COVID in Children Aug 21, 2024
    Show notes

    To address the need to characterize long COVID in children and adolescents, the National Institutes of Health funded a pediatric program in the Researching COVID to Enhance Recovery (RECOVER) Initiative. Editorialist Suchitra Rao, MBBS, MSCS, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, discusses this and more with JAMA Senior Editor Tracy A. Lieu, MD, MPH. Related Content:

    • Uncovering Long COVID in Children
    • Characterizing Long COVID in Children and Adolescents

    Uterus Transplant: Innovation and Considerations Aug 15, 2024
    Show notes

    A new study looks at uterus transplant to determine if it is safe, feasible, and results in births of healthy infants. Editorialist Emily Jungheim, MD, MSCI, Northwestern University, discusses this innovative treatment with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content:

    • Uterus Transplant—The Frontier of Innovative Fertility Treatment
    • Uterus Transplant in Women With Absolute Uterine-Factor Infertility

    A Vaping Cessation Text Message Program for Adolescents Aug 07, 2024
    Show notes

    Ten percent of US adolescents use e-cigarettes, and many want to quit. However, evidence on the effectiveness of vaping cessation interventions is lacking. Amanda L. Graham, PhD, of the Truth Initiative discusses with JAMA Senior Editor Tracy Lieu, MD, MPH, how a tailored, interactive text message intervention increased vaping cessation among adolescents recruited via social media channels. Related Content:

    • A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users
    • Supporting Adolescents' Desire to Quit E-Cigarettes
    • What Are E-Cigarettes?
    • Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues
    • E-Cigarette Use in Adults
    • Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth
    • Vaping in Youth
    • E-Cigarette Use in Adolescents and Adults—A JAMA Collection

    Diagnostic Accuracy of an Integrated AI Ultrasound Tool for Gestational Age Estimation Aug 01, 2024
    Show notes

    Gestational age estimation is foundational for obstetric care. In resource-limited settings, an integrated AI tool allows novice users to improve gestational age estimates. Author Jeffrey Stringer, MD, University of North Carolina, joins JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps. Related Content:

    • Diagnostic Accuracy of an Integrated AI Tool to Estimate Gestational Age From Blind Ultrasound Sweeps
    • Enhancing Obstetric Ultrasonography With Artificial Intelligence in Resource-Limited Settings

    Alzheimer Disease Blood Biomarkers Jul 28, 2024
    Show notes

    Biomarkers for Alzheimer disease (AD) provide insight into disease processes and may aid clinical diagnosis for individuals with cognitive impairment. Author Stephen Salloway, MD, MS, of Brown University joins JAMA Deputy Editor Christopher Muth, MD, to discuss 2 articles and an accompanying editorial about blood biomarkers for AD and potential implications for clinical practice. Related Content:

    • Are Blood Tests for Alzheimer Disease Ready for Prime Time?
    • Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
    • Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia

    Risankizumab for Ulcerative Colitis Jul 22, 2024
    Show notes

    Ulcerative colitis can significantly decrease quality of life. A third of patients have persistent symptoms with tumor necrosis factor inhibitors and nearly 1 in 5 patients will be hospitalized within 5 years of diagnosis. Author Gilaad G. Kaplan, MD, MPH, of the University of Calgary joins JAMA Associate Editor John M. Inadomi, MD, to discuss Risankizumab for Ulcerative Colitis. Related Content:

    • Monoclonal Antibody Risankizumab for Ulcerative Colitis
    • Risankizumab for Ulcerative Colitis

    Influence of Endometriosis Typology on Ovarian Cancer Risk Jul 17, 2024
    Show notes

    What are the ovarian cancer risks associated with endometriosis subtypes? Author Karen C. Schliep, PhD, MSPH, of the University of Utah joins JAMA Deputy Editor Linda Brubaker, MD, MS, to discuss Endometriosis Typology and Ovarian Cancer Risk. Related Content:

    • Endometriosis Typology and Ovarian Cancer Risk
    • New Insights in Endometriosis Subtypes and Ovarian Cancer Risk

    Nicotine Pouch Use in the US Jul 10, 2024
    Show notes

    Oral nicotine pouches are becoming more popular in the US, based on a survey performed in 2022. Hongying Daisy Dai, PhD, from Nebraska Medical Center, Omaha, discusses nicotine pouches and more with JAMA Deputy Editor Kristin L. Walter, MD, MS. Related Content:

    • Prevalence of Nicotine Pouch Use Among US Adults

    Previous 1 4 5 6 7 8 88 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights